Your browser doesn't support javascript.
loading
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models.
Zhang, Haohai; Feng, Lili; de Andrade Mello, Paola; Mao, Changchuin; Near, Richard; Csizmadia, Eva; Chan, Leo Li-Ying; Enjyoji, Keiichi; Gao, Wenda; Zhao, Haitao; Robson, Simon C.
  • Zhang H; Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Feng L; Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • de Andrade Mello P; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Mao C; Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Near R; Antagen Institute for Biomedical Research, Boston, Massachusetts, USA.
  • Csizmadia E; Antagen Institute for Biomedical Research, Boston, Massachusetts, USA.
  • Chan LL; Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Enjyoji K; Department of Advanced Technology R&D, Nexcelom from PerkinElmer, Lawrence, Massachusetts, USA.
  • Gao W; Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Zhao H; Antagen Institute for Biomedical Research, Boston, Massachusetts, USA.
  • Robson SC; Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
J Clin Invest ; 132(13)2022 07 01.
Article en En | MEDLINE | ID: mdl-35775486
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apirasa / Neoplasias Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apirasa / Neoplasias Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article